Advertisement

Topics

Omadacycline is noninferior to moxifloxacin in treating community acquired bacterial pneumonia

09:00 EST 11 Feb 2019 | 2 Minute Medicine

1. Intensive care unit (ICU) hospitalized adults with community acquired bacterial pneumonia had comparable clinical responses when taking antibiotic courses of omadacycline, a new trial antibiotic, versus moxifloxacin. 2. The observed safety profile of omadacycline was noted to be consistent with other known tetracyclines. Evidence Rating Level: 1 (Excellent) Study Rundown: Community acquired pneumonia is […]
Source: 2 Minute Medicine

Original Article: Omadacycline is noninferior to moxifloxacin in treating community acquired bacterial pneumonia

NEXT ARTICLE

More From BioPortfolio on "Omadacycline is noninferior to moxifloxacin in treating community acquired bacterial pneumonia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Pneumonia
Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae.  However,...